Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Kedudukan dalam Saham #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Harga Saham
$2.04
Disegerakkan terakhir: 2025-12-09
Modal Pasaran
$35.38M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-2.39%
Negara
IE
Perdagangan Mural Oncology plc (MURA)

Kategori

Sejarah harga saham bagi Mural Oncology plc (MURA)
Harga penutupan tertinggi: $2.04 pada 2025-12-01

Harga penutupan terendah: $3.85 pada 2023-11-01
Sejarah harga saham Mural Oncology plc dari 2023 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.23 6.53%
CH